In the latest installment of Knobbe Martens’ Law360 series on noteworthy Federal Circuit opinions, partners Sean Murray and Jeremiah Helm discuss the recent decision in Medtronic Inc. v. Teleflex Life Sciences Ltd….
Knobbe Martens partners Rosaleen Chou and Lauren Katzenellenbogen co-authored the article, “What’s In The USPTO Policy Pipeline This Year,” published in Law360. The article examines what intellectual property practitioners can…
Knobbe Martens partner Charlene Azema, together with Kunz-Hallstein Rechtsanwälte partner Roberto Kunz-Hallstein and Bird & Bird partner Géraldine Arbant, has co-authored an article for World Intellectual Property Review on the…
USPTO Announces New, Limited-Time Program for Expedited Semiconductor Patent Applications On December 1, 2023, the United States Patent and Trademark Office (“USPTO”) began accepting petitions for the Semiconductor Technology Pilot…
Partners Jeremiah Helm and Sean Murray analyzed the recent decision in Allgenesis Biotherapeutics Inc. v. Cloud Break Therapeutics in the latest installment of Knobbe Martens’ Law360 series on noteworthy Federal…
In the latest installment of Knobbe Martens’ Law360 series on noteworthy Federal Circuit opinions, partners Sean Murray and Jeremiah Helm discuss the recent decision in Elekta Limited v. ZAP Surgical Systems Inc….
On October 30, 2023, President Biden issued an Executive Order on the Safe, Secure, and Trustworthy Development and Use of Artificial Intelligence (the “AI EO”). The AI EO provides a…
In the latest installment of Knobbe Martens’ Law360 series on noteworthy Federal Circuit opinions, partner Jeremiah Helm writes about the Federal Circuit’s recent Netflix Inc. v. DivX LLC decision. The case, Helm…
Knobbe Martens attorneys Harnik Shukla, Vlad Teplitskiy, and Justin Theam authored the article “Leveraging Generative Artificial Intelligence in Business: Operations and Risks,” which was published on the Maple Business Council…
Knobbe Martens partner Andrea Cheek and associate Ari Feinstein authored “Patent Venue, and How It Works in Abbreviated New Drug Application Litigation,” published in Intellectual Property & Technology Law Journal….
